Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation
Abstract
ObjectiveParkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Autophagy dysfunction and astrocyte activation are considered important factors contributing to dopaminergic neuron death and the progression of Parkinson’s disease. Paeoniflorin, a monoterpene glycoside, exhibits multiple pharmacological effects, including anti-inflammatory, antioxidant, and immunomodulatory properties. The aim of this study was to investigate the effects of paeoniflorin on Parkinson’s disease and the underlying molecular mechanisms.MethodsUsing the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, the pharmacological effects of paeoniflorin were evaluated by behavioral assessment, immunohistochemical staining, and Western blotting. For the in vitro experiments, A1-phenotype astrocytes were induced with supernatant from LPS-stimulated microglia, and the regulatory effects of paeoniflorin on astrocyte activation were evaluated by immunofluorescence and Western blotting.ResultsPaeoniflorin ameliorated dopaminergic neuron damage and motor dysfunction in the MPTP-induced PD mouse model. Furthermore, paeoniflorin inhibited the activation of A1-phenotype astrocytes by promoting autophagy.ConclusionPaeoniflorin ameliorates Parkinson’s disease pathology by promoting autophagy and inhibiting the activation of A1-phenotype astrocytes. These findings uncover potential therapeutic targets and intervention strategies for Parkinson’s disease. Keywords: Parkinson’s disease; paeoniflorin; autophagy; A1-phenotype astrocytes; mTOR.
Related
- Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular Atrophy.
- Fejerin promotes autophagy via the PINK1-Parkin pathway and is protective against Parkinson’s disease pathology
- Disturbed expression of autophagy genes in blood of Parkinson’s disease patients
- Endoplasmic Reticulum Autophagy Enhancement Alleviates Synaptic Plasticity Dysfunction and Ameliorates Cognitive Impairment in SAE Mice by Relieving STING‐Associated Inhibition of PKM2 Activity
- The dual role of autophagy in gynecologic malignancies: promoting and inhibiting
BibTeX
@article{long2026paeoniflorin,
title = {{Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation}},
author = {Yijiao Long and Lihui Wang and Jun Yin and Baohua Hou},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1963824},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1963824},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation
AU - Yijiao Long
AU - Lihui Wang
AU - Jun Yin
AU - Baohua Hou
PY - 2026
DA - 2026/11/04
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1963824
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1963824
AB - ObjectiveParkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Autophagy dysfunction and astrocyte activation are considered important factors contributing to dopaminergic neuron death and the progression of Parkinson’s disease. Paeoniflorin, a monoterpene glycoside, exhibits multiple pharmacological effects, including anti-inflammatory, antioxidant, and immunomodulatory properties. The aim of this study was to investigate the effects of paeoniflorin on Parkinson’s disease and the underlying molecular mechanisms.MethodsUsing the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, the pharmacological effects of paeoniflorin were evaluated by behavioral assessment, immunohistochemical staining, and Western blotting. For the in vitro experiments, A1-phenotype astrocytes were induced with supernatant from LPS-stimulated microglia, and the regulatory effects of paeoniflorin on astrocyte activation were evaluated by immunofluorescence and Western blotting.ResultsPaeoniflorin ameliorated dopaminergic neuron damage and motor dysfunction in the MPTP-induced PD mouse model. Furthermore, paeoniflorin inhibited the activation of A1-phenotype astrocytes by promoting autophagy.ConclusionPaeoniflorin ameliorates Parkinson’s disease pathology by promoting autophagy and inhibiting the activation of A1-phenotype astrocytes. These findings uncover potential therapeutic targets and intervention strategies for Parkinson’s disease. Keywords: Parkinson’s disease; paeoniflorin; autophagy; A1-phenotype astrocytes; mTOR.
SN - 1663-9812
ER -